1. Home
  2. SBFM vs FE Comparison

SBFM vs FE Comparison

Compare SBFM & FE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • FE
  • Stock Information
  • Founded
  • SBFM 2006
  • FE 1996
  • Country
  • SBFM United States
  • FE United States
  • Employees
  • SBFM N/A
  • FE N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • FE Electric Utilities: Central
  • Sector
  • SBFM Health Care
  • FE Utilities
  • Exchange
  • SBFM Nasdaq
  • FE Nasdaq
  • Market Cap
  • SBFM 6.6M
  • FE 23.9B
  • IPO Year
  • SBFM N/A
  • FE N/A
  • Fundamental
  • Price
  • SBFM $1.47
  • FE $43.43
  • Analyst Decision
  • SBFM Strong Buy
  • FE Buy
  • Analyst Count
  • SBFM 1
  • FE 16
  • Target Price
  • SBFM $15.00
  • FE $46.14
  • AVG Volume (30 Days)
  • SBFM 43.5K
  • FE 3.2M
  • Earning Date
  • SBFM 11-04-2025
  • FE 10-28-2025
  • Dividend Yield
  • SBFM N/A
  • FE 4.10%
  • EPS Growth
  • SBFM N/A
  • FE 49.18
  • EPS
  • SBFM N/A
  • FE 2.27
  • Revenue
  • SBFM $36,341,741.00
  • FE $13,864,000,000.00
  • Revenue This Year
  • SBFM $32.20
  • FE $8.73
  • Revenue Next Year
  • SBFM $32.74
  • FE $3.41
  • P/E Ratio
  • SBFM N/A
  • FE $19.12
  • Revenue Growth
  • SBFM 19.22
  • FE 6.52
  • 52 Week Low
  • SBFM $1.17
  • FE $37.58
  • 52 Week High
  • SBFM $3.90
  • FE $44.58
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 52.23
  • FE 52.73
  • Support Level
  • SBFM $1.45
  • FE $43.05
  • Resistance Level
  • SBFM $1.53
  • FE $43.93
  • Average True Range (ATR)
  • SBFM 0.06
  • FE 0.49
  • MACD
  • SBFM 0.01
  • FE -0.09
  • Stochastic Oscillator
  • SBFM 68.57
  • FE 52.83

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About FE FirstEnergy Corp.

FirstEnergy is an investor-owned holding company with 10 regulated distribution utilities across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems.

Share on Social Networks: